Private company

Bellerophon Therapeutics (United States)

Company in Warren Township, United States.1

Last updated Oct 18, 2026.

Overview

2009Founded1
  • IndustryPharmaceutical Preparations1
  • HeadquartersWarren1
  • Websitewww.bellerophon.com
  • Incorporated inDE3
  • Business address184 Liberty Corner Road, Suite 302, Warren, Nj 070593
  • Filer categoryNon-accelerated filer, Smaller reporting company3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income45678-$22.4M in 2022−6% since 2016
-$30.0M-$20.0M-$10.0M02016: -$23.8M-$23.8M20162017: -$24.6M-$24.6M2017+4%2018: -$27.9M-$27.9M2018+13%2019: -$17.5M-$17.5M2019−37%2020: -$26.3M-$26.3M2020+50%2021: -$20.2M-$20.2M2021−23%2022: -$22.4M-$22.4M2022+11%
Net income45678-$19.8M in 2022−17% since 2016
-$60.0M-$40.0M-$20.0M0$20.0M2016: -$23.8M-$23.8M20162017: -$54.8M-$54.8M2017+130%2018: $2.8M$2.8M20182019: -$13.3M-$13.3M20192020: -$24.7M-$24.7M2020+86%2021: -$17.8M-$17.8M2021−28%2022: -$19.8M-$19.8M2022+12%
Fiscal year20162017201820192020202120222023
Operating income-$23.8M4-$24.6M5-$27.9M6-$17.5M7-$26.3M8-$20.2M8-$22.4M8
Income tax-$438.0K4$05-$5.4M6-$1.8M7-$2.1M8-$1.8M8-$2.4M8
Net income-$23.8M4-$54.8M5$2.8M6-$13.3M7-$24.7M8-$17.8M8-$19.8M8
Earnings per share-$1.584-$21.115$0.736-$2.957-$3.178-$1.878-$2.088
Earnings per share (diluted)-$1.584-$21.115-$5.076-$2.957-$3.178-$1.878-$2.088

Compare Bellerophon Therapeutics (United States) with another company

Former names

  • Bellerophon Therapeutics LLCFeb 21, 2014 to Feb 13, 20153

Timeline

  1. 2009Founded Founded1

Recent filings

  1. Mar 4, 20248-K
  2. Jan 30, 20248-K
  3. Jan 22, 20248-K
  4. Jan 10, 20248-K
  5. Dec 12, 20238-K
  6. Nov 21, 20238-K
  7. Nov 14, 202310-Q
  8. Nov 6, 2023DEF 14A
  9. Oct 16, 20234 PRIMARY DOCUMENT
  10. Oct 13, 20238-K
  11. Oct 13, 20238-K
  12. Aug 14, 202310-Q
  13. Aug 7, 20238-K
  14. Jul 24, 20238-K
  15. Jul 20, 20238-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2